Karyopharm Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Newton, MA
KPTI chart
What traders are saying about $KPTI
Latest postsKaryopharm Therapeutics Inc. news
- Karyopharm Therapeutics(KPTI) Stock Options Chain | Quotes & News
Moomoo ·
- Karyopharm Therapeutics stock sits 95.48 percent below target
ad-hoc-news.de ·
- Karyopharm stock: November 2 is the estimated results date for Karyopharm stock
ad-hoc-news.de ·
- Karyopharm Therapeutics Extends Forbearance Period to November 1, 2026
TradingView ·
- 12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga ·
- Why Is Karyopharm Therapeutics (NASDAQ:KPTI) Penny Stock Up 12% Today When No News Has Appeared?
kalkine.ca ·
- What Is Powering the Rally in Karyopharm Therapeutics, Estrella Immunopharma, CytoSorbents, MoonLake Immunotherapeutics, FibroBiologics, Exicure, Biohaven and Profusa Stocks Today, and What Should Investors Know About the Catalysts?
kalkine.ca ·
- What Is Behind the Double-Digit Climb in FST, Healthcare Services Group, Gaxos.ai, Sky Quarry, Cheche Group, Badger Meter, Karyopharm Therapeutics, SCWorx, Hotel101 Global and GrowHub, and Is It Worth Watching Today?
kalkine.ca ·
- KPTI Q3'26 Earnings: revenue estimate is 33.54M USD
TradingView ·
- Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use
biopharmadive.com ·
- Selinexor Sales Forecast and Market Size Analysis to 2034 | Selinexor Market Poised for Growth as Phase III Myelofibrosis Results Open New Commercial Opportunities
Yahoo Finance ·
Karyopharm Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $146.1M | $145.2M | $146.0M | $157.1M |
| Net income | -$196.0M | -$76.4M | -$143.1M | -$165.3M |
| Diluted EPS | $-17.93 | $-14.00 | $-18.79 | $-2.02 |
| Total assets (year end) | $108.4M | $164.4M | $240.4M | $358.2M |
| Cash and equivalents (year end) | $60.5M | $62.5M | $52.2M | $135.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Karyopharm Therapeutics Inc.
- Ticker
- KPTI (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Newton, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1503802
Frequently asked questions
What exchange is Karyopharm Therapeutics Inc. listed on?
Karyopharm Therapeutics Inc. trades on the Nasdaq under the ticker symbol KPTI.
What industry is Karyopharm Therapeutics Inc. in?
Karyopharm Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Karyopharm Therapeutics Inc. headquartered?
Karyopharm Therapeutics Inc.'s business address on file with the SEC is in Newton, MA.
When does Karyopharm Therapeutics Inc.'s fiscal year end?
Karyopharm Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Karyopharm Therapeutics Inc. report?
Karyopharm Therapeutics Inc. reported $146.1M in revenue for calendar year 2025, according to its SEC filings.